0001209191-20-030487.txt : 20200519
0001209191-20-030487.hdr.sgml : 20200519
20200519163131
ACCESSION NUMBER: 0001209191-20-030487
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200515
FILED AS OF DATE: 20200519
DATE AS OF CHANGE: 20200519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20894092
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Controller
Common Stock
2020-05-15
4
S
0
10
275.71
D
15073
D
Common Stock
2020-05-15
4
S
0
30
279.89
D
15043
D
Common Stock
2020-05-15
4
S
0
20
281.81
D
15023
D
Common Stock
2020-05-15
4
S
0
10
282.85
D
15013
D
Common Stock
2020-05-15
4
S
0
20
285.51
D
14993
D
Common Stock
2020-05-15
4
S
0
14
287.00
D
14979
D
Common Stock
2020-05-15
4
S
0
47
288.04
D
14932
D
Common Stock
169
I
401(k)
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $279.89 (range $279.42 to $280.19).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $281.81 (range $281.62 to $282.00).
Open market sales reported on this line occurred at a weighted average price of $285.51 (range $285.37 to $285.64).
Open market sales reported on this line occurred at a weighted average price of $287.00 (range $286.76 to $287.75).
Open market sales reported on this line occurred at a weighted average price of $288.04 (range $287.77 to $288.47).
/s/ Sabrina Yohai, Attorney-in-Fact
2020-05-19